Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: An 11-year nationwide cohort study

Annals of the Rheumatic Diseases

Volumn 75, Issue 7, 2016, Pages 1350-1356

  Lai, Chao Han ^a   Lai, Wu Wei ^a   Chiou, Meng Jiun ^b   Lin, Wei Chieh ^a   Yang, Yu Jen ^a   Li, Chung Yi ^b,c   Tsai, Liang Miin ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DISEASE; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INDEPENDENT VARIABLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; TREATMENT OUTCOME; VERY ELDERLY; ADVERSE EFFECTS; COMPLICATION; CORONARY ARTERY DISEASE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TAIWAN; TREATMENT OUTCOME;

EID: 84940199272     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207719     Document Type: Article

References (42)

1. Onat A, Direskeneli H. Excess cardiovascular risk in inflammatory rheumatic diseases: pathophysiology and targeted therapy. Curr Pharm Des 2012;18:1465-77.
2. Roifman I, Beck PL, Anderson TJ, et al. Chronic inflammatory diseases and cardiovascular risk: A systematic review. Can J Cardiol 2011;27:174-82.
3. Kaplan MJ. Management of cardiovascular disease risk in chronic inflammatory disorders. Nat Rev Rheumatol 2009;5:208-17.
4. Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337-47.
5. Gandhi S, Narula N, Marshall JK, et al. Are patients with inflammatory bowel disease at increased risk of coronary artery disease? Am J Med 2012;125:956-62.
6. Ungprasert P, Charoenpong P, Ratanasrimetha P, et al. Risk of coronary artery disease in patients with systemic sclerosis: A systematic review and meta-analysis. Clin Rheumatol 2014;33:1099-104.
7. Ward MM. Outcomes of hospitalizations for myocardial infarctions and cerebrovascular accidents in patients with systemic lupus erythematosus. Arthritis Rheum 2004;50:3170-6.
8. Van Doornum, S, Brand C, King B, et al. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:2061-8.
9. Van Doornum, S, Brand C, Sundararajan V, et al. Rheumatoid arthritis patients receive less frequent acute reperfusion and secondary prevention therapy after myocardial infarction compared with the general population. Arthritis Res Ther 2010;12:R183.
10. McCoy SS, Crowson CS, Maradit-Kremers H, et al. Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol 2013;40:605-10.
11. Francis ML, Varghese JJ, Mathew JM, et al. Outcomes in patients with rheumatoid arthritis and myocardial infarction. Am J Med 2010;123:922-8.
12. Douglas KM, Pace AV, Treharne GJ, et al. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 2006;65:348-53.
13. Sodergren A, Stegmayr B, Lundberg V, et al. Increased incidence of and impaired prognosis after acute myocardial infarction among patients with seropositive rheumatoid arthritis. Ann Rheum Dis 2007;66:263-6.
14. Ben-Zvi I, Goldenberg I, Matetzky S, et al. The impact of inflammatory rheumatic diseases on the presentation, severity, and outcome of acute coronary syndrome. Clin Rheumatol 2014. Published Online First: 15 June 2014. doi:10.1007/s10067-014-2695-y.
15. Kang JH, Keller JJ, Lin HC. Outcomes of nonstenting percutaneous coronary intervention in patients with rheumatoid arthritis. Am J Cardiol 2012;109:1160-3.
16. Desai SP, Januzzi JL, Pande AN, et al. Comparison of symptoms, treatment, and outcomes of coronary artery disease among rheumatoid arthritis and matched subjects undergoing percutaneous coronary intervention. Semin Arthritis Rheum 2010;40:215-21.
17. Varghese JJ, Koneru S, Scaife SL, et al. Mortality after coronary artery revascularization of patients with rheumatoid arthritis. J Thorac Cardiovasc Surg 2010;140:91-6.
18. Maksimowicz-McKinnon K, Selzer F, Manzi S, et al. Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: Report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circ Cardiovasc Interv 2008;1:201-8.
19. Chung WS, Peng CL, Lin CL, et al. Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: A nationwide cohort study. Ann Rheum Dis 2014;73:1774-80.
20. Lai CC, Wang SH, Chen WS, et al. Increased risk of osteoporotic fractures in patients with systemic sclerosis: A nationwide population-based study. Ann Rheum Dis 2015;74:1347-52.
21. Weng MY, Huang YT, Liu MF, et al. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan. Ann Rheum Dis 2012;71:524-7.
22. Lin JA, Liao CC, Lee YJ, et al. Adverse outcomes after major surgery in patients with systemic lupus erythematosus: A nationwide population-based study. Ann Rheum Dis 2014;73:1646-51.
23. Kip KE, Hollabaugh K, Marroquin OC, et al. The problem with composite end points in cardiovascular studies: The story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol 2008;51:701-7.
24. Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2010;122:949-57.
25. Hsieh TH, Wang JD, Tsai LM. Improving in-hospital mortality in elderly patients after acute coronary syndrome-a nationwide analysis of 97, 220 patients in Taiwan during 2004-2008. Int J Cardiol 2012;155:149-54.
26. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961-72.
27. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
28. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford) 2003;42:607-13.
29. Avina-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-7.
30. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis Rheum 2005;52:402-11.
31. Yalamanchili K, Aronow WS, Kilaru R, et al. Coronary artery disease is more severe in older persons with rheumatoid arthritis than in older persons without rheumatoid arthritis. Cardiol Rev 2006;14:55-6.
32. Warrington KJ, Kent PD, Frye RL, et al. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: A case control study. Arthritis Res Ther 2005;7:984-91.
33. Aubry MC, Maradit-Kremers H, Reinalda MS, et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007;34:937-42.
34. Semb AG, Rollefstad S, Provan SA, et al. Carotid plaque characteristics and disease activity in rheumatoid arthritis. J Rheumatol 2013;40:359-68.
35. Semb AG, Rollefstad S, van Riel, P, et al. Cardiovascular disease assessment in rheumatoid arthritis: A guide to translating knowledge of cardiovascular risk into clinical practice. Ann Rheum Dis 2014;73:1284-8.
36. Karpouzas GA, Malpeso J, Choi TY, et al. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease. Ann Rheum Dis 2014;73:1797-804.
37. Holmes DR, Selzer F, Johnston JM, et al. Modeling and risk prediction in the current era of interventional cardiology: A report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circulation 2003;107:1871-6.
38. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009;5:50-6.
39. Palmerini T, Genereux P, Caixeta A, et al. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial. J Am Coll Cardiol 2011;57:2389-97.
40. Calvert PA, Obaid DR, O'Sullivan M, et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: The VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. JACC Cardiovasc Imaging 2011;4:894-901.
41. Wu C, Hannan EL, Walford G, et al. A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol 2006;47:654-60.
42. Chang GM, Cheng SH, Tung YC. Impact of cuts in reimbursement on outcome of acute myocardial infarction and use of percutaneous coronary intervention: A nationwide population-based study over the period 1997 to 2008. Med Care 2011;49:1054-61.